ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs MXN
18.4648
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,092.27
-0.15%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Mangoceuticals Inc (MGRX)

  7. Mangoceuticals Inc (MGRX) Noticias

MGRX Mangoceuticals Inc

0.322
-0.0181 (-5.32%)
14 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Mangoceuticals Inc MGRX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.0181 -5.32% 0.322 23:00:03
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.3456 0.30 0.35 0.3199 0.3401
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
10/6/202412:28EDGAR2Form 144 - Report of proposed sale of securities
06/6/202407:30GLOBEMangoRx Receives Notice of Acceptance for Patent Application..
05/6/202416:15EDGAR2Form 8-K - Current report
05/6/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202415:00GLOBEMangoRx Receives Patent Notice of Allowance in Japan for..
04/6/202407:00GLOBEMangoRx to Introduce “MOJO” Pharmaceutical Compounded..
28/5/202407:30GLOBEMangoceuticals, Inc. Announces Completion of First Batch of..
23/5/202407:30GLOBEMangoRx Engages Renown International Digital and Performance..
21/5/202407:30GLOBEMangoRx to Introduce Oral Semaglutide and Tirzepatide in..
16/5/202415:40GLOBEMangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by..
16/5/202412:59EDGAR2Form ARS - Annual Report to Security Holders
16/5/202408:19EDGAR2Form DEF 14A - Other definitive proxy statements
15/5/202415:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202408:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/5/202416:32EDGAR2Form S-1/A - General form for registration of securities..
06/5/202415:43EDGAR2Form PRE 14A - Other preliminary proxy statements
02/5/202407:00GLOBEMangoceuticals Granted 180-Day Extension to Meet Nasdaq..
25/4/202407:30GLOBEMangoceuticals Acquires Global Patent Portfolio to..
12/4/202407:45GLOBEMangoceuticals Subsidiary, MangoRx Mexico, Executes..
12/3/202408:00GLOBEMangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by..
20/2/202408:00GLOBEMangoRx Launches Direct-To-Clinics Sales Division to Drive..
13/2/202407:00GLOBEMANGORX AWARDS SAN FRANCISCO TEAM FREE MANGORX ED PRODUCTS..
06/2/202408:00GLOBEMANGORX TO OFFER THE BIG GAME’S LOSING TEAM A FREE ONE YEAR..
05/2/202407:50GLOBEMangoRx Accepting Pre Orders for its “PRIME”, by MangoRx,..
19/1/202407:00GLOBEMangoRx’s Brand and Products to be Featured by Barstool..
15/12/202309:39GLOBEMangoceuticals, Inc. Announces Pricing of $1,200,000 Public..
13/12/202306:30GLOBEMANGOCEUTICALS TO INTRODUCE “PRIME”, POWERED BY KYZATREX®️..
06/12/202307:00GLOBEMangoceuticals Launches MangoRx Mexico Subsidiary, Paving..
29/11/202307:30GLOBEMangoceuticals Selects TRYBE Labs as its Nationwide Blood..
02/11/202308:15GLOBEMangoceuticals, Inc. Launches Charitable Initiative in..
26/10/202306:30GLOBEMangoceuticals Launches TikTok Influencer Initiative and..
19/10/202308:00GLOBEMangoceuticals, Inc. Provides Update to Shareholders on Q3..
13/10/202308:40GLOBEMangoceuticals Announces TV Air Dates for Interview..
13/10/202308:12GLOBENew to The Street Airs Televised Corporate Interviews..
12/10/202308:15GLOBEMangoceuticals Announces the Official Launch of MangoRx..
14/9/202305:00GLOBEMangoceuticals Brand MangoRx Announced as Raindance Film..
08/9/202309:38GLOBEUPDATE: New to The Street Proudly Announces its 500th..
08/9/202308:30GLOBENew to The Street Proudly Announces its 500th Special..
07/9/202307:00GLOBEMangoceuticals Expands its Nationwide Marketing Efforts with..
30/8/202307:00GLOBEMangoceuticals Launches New High-Production Quality Ad..
16/8/202307:00GLOBEMangoceuticals Launches New Sildenafil Based Erectile..
09/8/202307:00GLOBEMangoceuticals Partners with Greater NY Chamber of Commerce..
02/8/202307:00GLOBEMangoceuticals, Inc. Names Award Winning Globally Recognized..
01/8/202307:00GLOBEMangoceuticals Engages Premier Global Software Development..
27/7/202307:00GLOBEMangoceuticals, Inc. Adds Top Men’s Podcast, Pillow Talk..
24/7/202309:47GLOBENew to The Street TV Announces Episode 491 with its Five..
21/7/202308:30GLOBENew to The Street Announces its Five Corporate Interviews,..
18/7/202309:00GLOBEMangoceuticals Engaged by Social Media Sensation Adam22 as..
12/7/202309:00GLOBEMangoceuticals, Inc. Announces TV Air Dates for Interview..

Su Consulta Reciente

NASDAQ
MGRX
Mangoceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados